Across TCGA pan-cancer cohorts, BMP1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated BMP1 data layer compared with 10 for mutation status and 7 for mass-spec protein.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher BMP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BMP1 expression acts as an unfavorable survival marker, although some lineages such as DLBC and THCA show a favorable association.
KIRC, ACC, and MESO are the cancer types where BMP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.